How should acute pharyngeal tonsillitis be managed?

Management of Acute Pharyngeal Tonsillitis

Penicillin or amoxicillin for 10 days is the treatment of choice for confirmed Group A Streptococcal (GAS) pharyngitis, but only after proper diagnostic confirmation—clinical diagnosis alone is insufficient and leads to massive antibiotic overuse. 1

Diagnostic Approach

Do Not Treat Based on Clinical Appearance Alone

The signs and symptoms of bacterial and viral pharyngitis overlap so extensively that clinical diagnosis alone is unreliable. 1 Only 20-30% of children and 5-15% of adults with acute pharyngitis actually have GAS infection. 1 Treating everyone with a sore throat means unnecessarily exposing 70-80% of patients to antibiotics they don't need, driving antimicrobial resistance. 1

Use a Structured Diagnostic Algorithm

1. Apply a clinical scoring system (Centor or McIsaac score):

   • Tonsillar exudate: 1 point
   • Tender anterior cervical lymphadenopathy: 1 point
   • Fever >38°C: 1 point
   • Absence of cough: 1 point
   • Age 3-14 years: 1 point (McIsaac modification)
   • Age 15-44 years: 0 points
   • Age ≥45 years: -1 point

2. If score <3: Do not test or treat—viral etiology is most likely 1

3. If score ≥3: Perform rapid antigen detection test (RADT) or throat culture 1

   • In children/adolescents: Negative RADT must be backed up with throat culture (high sensitivity needed due to rheumatic fever risk)
   • In adults: Backup culture not routinely needed (rheumatic fever risk is exceptionally low)
   • Positive RADT: No backup needed—specificity is excellent 1

Do Not Test or Treat These Patients

• Children <3 years old (rheumatic fever is rare, and classic streptococcal presentation is uncommon in this age group) 1
• Patients with obvious viral features: cough, rhinorrhea, hoarseness, oral ulcers 1
• Asymptomatic household contacts 1

Treatment When GAS is Confirmed

First-Line Antibiotic Therapy (Non-Penicillin Allergic)

Penicillin remains the gold standard because GAS has never developed resistance to it, it has narrow spectrum activity, minimal adverse effects, and low cost. 1

Specific regimens:

• Penicillin V oral:

  • Children: 250 mg twice or three times daily × 10 days
  • Adolescents/adults: 250 mg four times daily OR 500 mg twice daily × 10 days 1

• Amoxicillin oral (preferred for young children due to better taste):

  • 50 mg/kg once daily (max 1000 mg) × 10 days, OR
  • 25 mg/kg twice daily (max 500 mg/dose) × 10 days 1

• Benzathine penicillin G intramuscular (single dose—ensures compliance):

  • <27 kg: 600,000 units
  • ≥27 kg: 1,200,000 units 1

Penicillin-Allergic Patients

For non-anaphylactic penicillin allergy:

• Cephalexin: 20 mg/kg/dose twice daily (max 500 mg/dose) × 10 days 1
• Cefadroxil: 30 mg/kg once daily (max 1 g) × 10 days 1

For immediate/anaphylactic penicillin allergy:

• Clindamycin: 7 mg/kg/dose three times daily (max 300 mg/dose) × 10 days 1
• Clarithromycin: 7.5 mg/kg/dose twice daily (max 250 mg/dose) × 10 days 1
• Azithromycin: 12 mg/kg once daily (max 500 mg) × 5 days 1

Critical caveat: Macrolide resistance varies geographically and temporally—these are not first-line agents. 1

Duration Matters

The full 10-day course is essential for most antibiotics to achieve maximal pharyngeal eradication of GAS and prevent rheumatic fever. 2, 1 Only azithromycin has FDA approval for 5 days. 1

Symptomatic Management

Adjunctive Therapy

• Acetaminophen or NSAIDs (ibuprofen, naproxen) for moderate-to-severe symptoms or high fever 1
• Avoid aspirin in children (Reye syndrome risk) 1
• Corticosteroids are not recommended 1

Viral Pharyngitis (No GAS Identified)

Supportive care only: hydration, analgesia, rest. 3 Antibiotics provide no benefit and cause harm through adverse effects and resistance promotion. 1

What NOT to Do

Common Pitfalls to Avoid

1. Do not perform routine follow-up throat cultures or RADT after treatment—clinical response within 24-48 hours is expected 1

2. Do not test or treat asymptomatic household contacts—despite 30% transmission rates, prophylaxis is ineffective and risks outweigh benefits 1

3. Do not check anti-streptolysin O (ASO) titers for acute diagnosis—they reflect past, not current infection 1

4. Do not routinely perform blood tests, ECG, or urine studies for uncomplicated acute tonsillitis 4

5. Do not use broad-spectrum antibiotics as first-line therapy—this drives resistance without improving outcomes 1

Why This Matters for Morbidity and Mortality

The primary goal of treating GAS pharyngitis is preventing acute rheumatic fever, which remains the leading cause of acquired heart disease in children in developing regions. 2, 1 Secondary goals include preventing suppurative complications (peritonsillar abscess, cervical lymphadenitis, mastoiditis) and reducing symptom duration and transmission. 1

However, inappropriate antibiotic use for viral pharyngitis causes direct patient harm (adverse drug reactions, including rare anaphylaxis) and population-level harm (antimicrobial resistance). 1 The evidence-based approach outlined above balances these competing risks by restricting antibiotics to confirmed bacterial cases while ensuring those who need treatment receive it promptly.